CD44 and intrahepatic cholangiocarcinoma: Since it has been early reported that the SPP1-CD44 ligand-receptor pair causes immunosuppression in intrahepatic cholangiocarcinoma progression27, we speculated that the augmented apCAF abundance in CRC patients may potentially induce immune escape.